‘We intend to stop the study’: COVID trials canceled because no one wants to be a test subject

There’s much evidence that while the COVID-19 pandemic, originating apparently at a research lab in China, truly was a lethal virus, the “vaccines” caused a lot of health injuries, too.

They actually were more DNA treatments than vaccines, and those who took the shots were hit with heart troubles, including some resulting in fatalities, and other ailments.

Despite this, the medical industry has continued to push them, and among the latest moves are by Pfizer and BioNTech who wanted to do studies on their vaccines.

A new report from Biopharma Dive, however, explains those studies have been halted “due to low enrollment.”

The two companies, both of whom produced and sold the COVID-19 shots for billions of dollars during the pandemic that killed millions around the globe, confirmed they are halting a government-ordered post-marketing study “because of recruitment issues that, in turn, have impaired data collection.”

The two said they are suspending the trial and they explained that it was because of “lower-than-expected enrollment due to a slow season of COVID.”

The report explained, “The trial is tied to a post-marketing commitment that Food and Drug Administration Commissioner Martin Makary put in place last year for all approved COVID vaccines.”

A Pfizer statement confirmed, “We intend to stop the study due to slow enrollment and therefore the inability to generate relevant post-marketing data.”

The report outlined that, “The study was meant to evaluate if the COVID vaccine was more effective than a placebo in healthy adults aged 50 to 64 years old. It was expected to amass 25,500 participants and designed to measure safety, immune response and prevention of COVID cases.”

The backlash to the complications from the COVID shots previously included new stricter approval standards including the requirement of a placebo control arm in tests as well as reduce availability of the shots due to restrictions from the Centers for Disease Control and Prevention.

Further, HHS Secretary Robert F. Kennedy Jr. said the vaccines would no longer be recommended for healthy children and pregnant people.

It was Reuters who also reported on the moves.

“In a letter to trial ‌investigators dated March 30, seen by Reuters and previously unreported, Pfizer said it would stop surveillance for signs of COVID illness for all participants in the study after April 3,” the report said.

That publication said, “The trial aimed to test the efficacy, immune response and safety of an updated COVID vaccine from Pfizer and BioNTech in healthy adults aged 50 to 64. The FDA required participants have no chronic conditions such as hypertension or diabetes.”